, Volume 10, Issue 4, pp 434–435 | Cite as

The authors reply

  • Greg L. Plosker
  • Paul Benfield


Ondansetron Metoclopramide Granisetron Tropisetron Drug Acquisition Cost 


  1. 1.
    Plosker GL, Benlield P, Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy inducednausea and vomiting. Pharmacoeconomics 1996 Apr; 9 (4): 357–74Google Scholar
  2. 2.
    O’Brien BJ, Rusthoven J, Rocchi A, et al. Impact of chemotherapy— associated nausea and vomiting on patients’ functional status and on costs: survey of live Canadian centres. Can Med Assoc J 1993 Aug 1; 149: 296–302Google Scholar
  3. 3.
    Jobet I, Zyguel S, Prugnaud JL. Economic evaluation of anti−5HT3: development of an economic model for cost minimisation study [in French]. J Pharm Clin 1995 Mar; 14: 55–63Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Greg L. Plosker
    • 1
  • Paul Benfield
    • 1
  1. 1.Adis International LimitedNew Zealand

Personalised recommendations